Welcome to our dedicated page for SURO CAPITAL SEC filings (Ticker: SSSSL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SURO CAPITAL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SURO CAPITAL's regulatory disclosures and financial reporting.
Neostellar Capital Corp. reported preliminary second-quarter 2026 results, estimating net asset value at $13.25 to $13.75 per share as of June 30, 2026. Net assets were previously $361.6 million, or $14.24 per share, as of March 31, 2026.
The company completed its full $20.0 million commitment to TensorWave via Magnetar Opportunity 2025-4 LP and invested $9.5 million in ClickHouse, Inc., both focused on AI and enterprise infrastructure. It also exited or harvested gains from vehicles tied to CoreWeave, GrabAGun Digital Holdings, and HL Digital Assets, generating several million dollars of proceeds and realized gains.
As of June 30, 2026, Neostellar held positions in 37 portfolio companies, with liquid assets of about $14.7 million and 26,473,222 common shares outstanding. The company recently rebranded from SuRo Capital Corp. and expects to complete a transition to an externally managed structure, subject to customary regulatory approvals, and plans to announce full second-quarter results in August 2026.
SuRo Capital Corp. is changing its corporate name to Neostellar Capital Corp. Effective July 1, 2026, this name change will take effect following the filing of Articles of Amendment with the Maryland State Department of Assessments and Taxation.
On or about the same date, the Nasdaq trading symbol for the company’s common stock will change from SSSS to NSLR, and the symbol for its 6.00% Notes due 2026 will change from SSSSL to NSLRL. The board of directors approved the Articles of Amendment and related Third Amended and Restated Bylaws, which update the bylaws only to reflect the new name. Stockholder approval was not required under Maryland law or the company’s charter and bylaws.
SuRo Capital Corp. director Ronald M. Lott reported an open-market sale of 500 shares of Common Stock at $12.35 per share. After this sale on June 23, 2026, he directly holds 3,036 shares. He also has indirect ownership of 18,481 shares through a family trust.
A footnote explains that these indirectly held shares include restricted shares granted under the SuRo Capital Corp. Second Amended and Restated 2019 Equity Incentive Plan. Vesting of the company’s unvested restricted shares was accelerated in full effective June 15, 2026, following stockholder approval of the company’s externalization and related board action.
SSSS (issuer): Notice of proposed sale of Common stock. The filing lists 500 shares of Common stock described as acquired as compensation — Restricted Stock Units with an acquisition date of 06/05/2025. The filer also reports prior selling activity: 10,669 shares sold on 04/28/2026 for $137,586.36. The selling party is identified as the Ronald M. Lott Family Trust.
SuRo Capital Corp. officer Allison Green reported equity compensation changes. On June 12, 2026, Green was granted 60,000 restricted common shares that vest one-third each on June 12, 2027, 2028, and 2029 under the Second Amended and Restated 2019 Equity Incentive Plan.
On June 15, 2026, SuRo Capital’s board approved acceleration of Green’s unvested restricted shares in connection with stockholder approval of the company’s externalization, conditioned on a lock-up agreement mirroring the original vesting schedules. That day, 41,815 shares were withheld at $13.56 per share to cover tax obligations, leaving 207,990 common shares held directly.
SuRo Capital Corp. Chairman, CEO and President Mark D. Klein reported compensation-related stock transactions. On June 12, 2026, he received a grant of 350,000 restricted shares of common stock at no cost, vesting in three equal parts on June 12, 2027, 2028 and 2029.
On June 15, 2026, 293,265 shares were withheld to cover his tax obligations upon vesting of restricted shares at a price of $13.56 per share, a disposition treated as a tax payment rather than an open-market sale. After these transactions, he directly owned 1,732,756 shares, including shares previously granted and shares beneficially owned through his spouse. The filing also notes that, in connection with stockholder approval of the company’s externalization, the board accelerated the vesting of his remaining unvested restricted shares subject to his entry into a lock-up agreement mirroring the original vesting periods.
Westley Lisa reported acquisition or exercise transactions in this Form 4 filing.
SuRo Capital Corp. director Lisa Westley received a grant of 3,536 shares of restricted common stock as equity compensation. The shares were granted at no cash cost and are scheduled to vest in full on the earlier of the first anniversary of the award date, June 10, 2027, or the company’s annual shareholder meeting closest to that date. Following this award, Westley directly holds 58,831 common shares. The board may, in its sole discretion, accelerate vesting in connection with stockholder approval of the company’s externalization.
Mazur Marc reported acquisition or exercise transactions in this Form 4 filing.
SuRo Capital Corp. director Marc Mazur received a grant of 3,536 shares of common stock as an equity award. The shares are restricted and were granted at no cash cost per share. Following the award, Mazur directly holds 68,950 shares of SuRo Capital common stock.
The restricted shares are scheduled to vest in full on the earlier of the first anniversary of the award date, with that anniversary falling on June 10, 2027, or the date of SuRo Capital’s annual stockholder meeting closest to that anniversary. The Board of Directors may, in its sole discretion, accelerate vesting of these shares in connection with stockholder approval of the company’s externalization.
Szuch Richard C. reported acquisition or exercise transactions in this Form 4 filing.
SuRo Capital Corp. director Richard C. Szuch received a grant of 3,536 shares of common stock as a restricted stock award. The shares were granted at no cash cost and increase his direct holdings to 9,303 shares.
The restricted shares were granted under the SuRo Capital Corp. Second Amended and Restated 2019 Equity Incentive Plan and are scheduled to vest in full on the earlier of the first anniversary of the award date, June 10, 2027, or the company’s annual stockholder meeting closest to that date. The board may, in its sole discretion, accelerate vesting in connection with stockholder approval of the company’s externalization.
LOTT RONALD M. reported acquisition or exercise transactions in this Form 4 filing.
SuRo Capital Corp. director Ronald M. Lott reported an equity grant and updated his holdings. He received a grant of 3,536 restricted shares of common stock at no cost under the Second Amended and Restated 2019 Equity Incentive Plan. These restricted shares are scheduled to vest in full on the earlier of the first anniversary of the award date, June 10, 2027, or the SuRo Capital Corp. annual stockholder meeting closest to that date, with potential acceleration at the board’s discretion in connection with stockholder approval of the company’s externalization. Following this grant, Lott holds 3,536 shares directly and 18,481 shares indirectly through the Ronald M. Lott Family Trust, where he is trustee and beneficiary and disclaims beneficial ownership except for his pecuniary interest.